Company Filing History:
Years Active: 1997
Title: The Innovative Contributions of Stephen Brown
Introduction
Stephen Brown is a notable inventor based in Northumberland, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 2 patents to his name, Brown's work has the potential to impact cancer treatment significantly.
Latest Patents
One of his latest patents is for "Lyophilized thioxanthenone antitumor agents." This patent discloses reconstituted lyophilized formulations for the treatment of mammalian tumors, which comprise a thioxanthenone antitumor agent combined with mannitol or sucrose as a stabilizer in a lactate buffer. Another significant patent is for an "Oral gel capsule formulation of 1,2,4-benzotriazine oxides." This invention involves anticancer tumor soft gelatin capsules that contain a 1,2,4-benzotriazine oxide and an oily excipient selected from soybean oil and fractionated coconut oil.
Career Highlights
Throughout his career, Stephen Brown has worked with prominent companies in the pharmaceutical industry, including Sanofi Winthrop Inc. and Sanofi. His experience in these organizations has allowed him to develop innovative solutions for cancer treatment.
Collaborations
Brown has collaborated with several professionals in his field, including Gurdial Singh Sandhu and Ross Blundell. These collaborations have likely contributed to the advancement of his research and inventions.
Conclusion
Stephen Brown's contributions to the field of pharmaceuticals, particularly in cancer treatment, are noteworthy. His innovative patents and collaborations highlight his commitment to advancing medical science.